LexDanaLexDanabeta
Inventor

KWAN HYUNG CHO

Inventor
KR

Overview

2→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07BGeneral methods of organic chemistry25%
C07DHeterocyclic compounds25%
PatentTitleYear
11,858,894Crystalline form of 1-(5-(2,4-Difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-n-methylmethanamine salt202411,459,297Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to DAEWOONG PHARMACEUTICAL CO LTD (2)· patent assignee history
2022–2024Based in KR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DAEWOONG PHARMACEUTICAL CO LTD22022–2024
Locations
LocationPatentsSpan
KR22022–2024